Axon Enterprise reported a record $681 million in revenue for 2020, a 28% increase year-over-year, with Q4 2020 revenue growing 32% to $226 million. The company saw strong profitability and global demand for TASER devices, and raised its 2021 outlook.
Q4 2020 revenue grew 32% year over year to $226 million.
The quarter benefitted from a $20 million TASER 7 order from an international customer.
Annual Recurring Revenue (ARR) grew 37% year over year to $221 million.
Net income per diluted share was $0.40, while Non-GAAP EPS was $1.00.
Axon expects to achieve revenue in the range of $740 million to $780 million and Adjusted EBITDA to $125 million to $140 million for 2021. The company expects Q1 2021 revenue to grow approximately 12% year over year.
Visualization of income flow from segment revenue to net income